Published in Pain Med on September 01, 2000
Preparation, confidence, and attitudes about chronic noncancer pain in graduate medical education. J Grad Med Educ (2010) 0.97
Factors affecting hospital staff judgments about sickle cell disease pain. J Behav Med (2006) 0.90
Effect of treatment success and empathy on surgeon attributions for back surgery outcomes. J Behav Med (2005) 0.80
Medical Evidence Influence on Inpatients and Nurses Pain Ratings Agreement. Pain Res Manag (2016) 0.75
Psychological Distress in Out-Patients Assessed for Chronic Pain Compared to Those with Rheumatoid Arthritis. Pain Res Manag (2016) 0.75
Reliability in pain practice: chimera or reality? Pain Med (2000) 0.75
Judging pain and disability: effects of pain severity and physician specialty. J Behav Med (2010) 0.75
Taking into account the observers' uncertainty: a graduated approach to the credibility of the patient's pain evaluation. J Behav Med (2009) 0.75
Protein expression in E. coli minicells by recombinant plasmids. Cell (1977) 8.74
The rapid purification of T4 DNA ligase from a lambda T4 lig lysogen. J Biol Chem (1980) 4.82
Altered tetracycline resistance in pSC101 recombinant plasmids. Mol Gen Genet (1977) 3.03
On the nature of tetracycline resistance controlled by the plasmid pSC101. Cell (1978) 2.80
The aminoglycoside-resistance operon of the plasmid pSa: nucleotide sequence of the streptomycin-spectinomycin resistance gene. Gene (1985) 2.51
Genetic map of the crown gall suppressive IncW plasmid pSa. Mol Gen Genet (1982) 2.33
A rating system for use with patient pain drawings. Pain (1986) 2.10
The Pain Disability Index: psychometric and validity data. Arch Phys Med Rehabil (1987) 2.01
Regulation of Ti plasmid virulence genes by a chromosomal locus of Agrobacterium tumefaciens. J Bacteriol (1985) 1.96
Oral anticoagulation and hemorrhagic complications in an elderly population with atrial fibrillation. Arch Intern Med (2001) 1.82
Clinical guidelines for testing for heritable thrombophilia. Br J Haematol (2010) 1.79
A prospective randomized study to determine the optimal dose of intravenous vitamin K in reversal of over-warfarinization. Br J Haematol (2000) 1.70
Identification of pTiC58 plasmid-encoded proteins for virulence in Agrobacterium tumefaciens. Proc Natl Acad Sci U S A (1985) 1.59
Lipoprotein (a), cholesterol and triglycerides in women with venous thromboembolism. Blood Coagul Fibrinolysis (2000) 1.50
Flow cytometry in diagnosis and management of large fetomaternal haemorrhage. J Clin Pathol (1995) 1.50
Vitamin B12 deficiency following restorative proctocolectomy. Colorectal Dis (2007) 1.49
Characteristics of monoclonal immunoglobulins that interfere with serum inorganic phosphate measurement. Ann Clin Biochem (1994) 1.44
Injecting drug use is a risk factor for deep vein thrombosis in women in Glasgow. Br J Haematol (2001) 1.44
The cancer-associated retinopathy antigen is a recoverin-like protein. Invest Ophthalmol Vis Sci (1992) 1.44
DNA repair in Escherichia coli mutants deficient in DNA polymerases I, II and-or 3. Proc Natl Acad Sci U S A (1974) 1.43
Risk factors for pregnancy associated venous thromboembolism. Thromb Haemost (1997) 1.37
Test-retest reliability of the pain drawing instrument. Pain (1988) 1.34
Pain assessment in cognitively impaired and unimpaired older adults: a comparison of four scales. Pain (2001) 1.33
The Pain Disability Index: factor structure and normative data. Arch Phys Med Rehabil (1994) 1.26
A study of Protein S antigen levels in 3788 healthy volunteers: influence of age, sex and hormone use, and estimate for prevalence of deficiency state. Br J Haematol (2001) 1.22
Analysis of natural killer effector and suppressor activity by intraepithelial lymphocytes from mouse small intestine. Clin Exp Immunol (1983) 1.18
Relationship between social desirability and self-report in chronic pain patients. Clin J Pain (1995) 1.12
Predicting disease recurrence in patients with previous unprovoked venous thromboembolism: a proposed prediction score (DASH). J Thromb Haemost (2012) 1.11
Isolation of the origin of replication of the IncW-group plasmid pSa. Gene (1982) 1.11
'Last-ditch' use of recombinant factor VIIa in patients with massive haemorrhage is ineffective. Vox Sang (2004) 1.08
Molecular characterization of the virC genes of the Ti plasmid. J Bacteriol (1987) 1.08
Evaluation of the effects of single-nucleotide polymorphisms in CYP3A4 and CYP4F2 on stable phenprocoumon and acenocoumarol maintenance doses: comment. J Thromb Haemost (2014) 1.07
Does the clinical presentation and extent of venous thrombosis predict likelihood and type of recurrence? A patient-level meta-analysis. J Thromb Haemost (2010) 1.06
Restriction endonuclease mapping of pSC101 and pMB9. Mol Gen Genet (1978) 0.97
Platelet and cardiac function in Darier's disease. Clin Exp Dermatol (2001) 0.96
Polymerase chain reaction for detection of Mycoplasma gallisepticum. Avian Dis (1991) 0.96
Prevalence of the post-thrombotic syndrome in young women with previous venous thromboembolism. Br J Haematol (2000) 0.95
Isolation and characterization of the phosphoglucose isomerase gene from Escherichia coli. Mol Gen Genet (1989) 0.94
The role of hepatitis C virus in the aetiology of non-Hodgkins lymphoma--a regional association? Leuk Lymphoma (1997) 0.93
Restarting anticoagulation in prosthetic heart valve patients after intracranial haemorrhage: a 2-year follow-up. Br J Haematol (1998) 0.93
Dementia in subjects with atrial fibrillation: hemostatic function and the role of anticoagulation. J Thromb Haemost (2004) 0.91
Development of resistance to activated protein C during pregnancy. Br J Haematol (1995) 0.90
The Psychosomatic Symptom Checklist revisited: reliability and validity in a chronic pain population. J Behav Med (1989) 0.90
Are atrial fibrillation guidelines altering management? A community based study. Scott Med J (2005) 0.87
A virtual molecular biology teaching laboratory. Biotechniques (1999) 0.87
Disability management of low back injuries by employer-retained physicians: ratings and costs. Am J Ind Med (2000) 0.87
Isolation and characterization of the hisG and hisD genes of Klebsiella pneumoniae. Gene (1981) 0.87
The effects of medical evidence and pain intensity on medical student judgments of chronic pain patients. J Behav Med (1997) 0.86
Purification of restriction endonuclease XcyI from Xanthomonas cyanopsidis. Gene (1984) 0.86
Noonan syndrome: coagulation and clinical aspects. Acta Paediatr (1996) 0.84
Prothrombin 20210 G-->A, MTHFR C677T mutations in women with venous thromboembolism associated with pregnancy. BJOG (2000) 0.84
A comparison of the origin of replication of pSa with R6K. Mol Gen Genet (1983) 0.84
Low thrombosis rate seen in blood donors and their relatives with inherited deficiencies of antithrombin and protein C: correlation with type of defect, family history, and absence of the factor V Leiden mutation. Blood Coagul Fibrinolysis (1996) 0.84
Brain isozyme of glycogen phosphorylase: immunohistological localization within the central nervous system. Brain Res (1990) 0.84
Management of oral anticoagulant-induced intracranial haemorrhage. Blood Rev (1998) 0.83
Roles for E. coli DNA polymerases I, II, and 3 in DNA replication. Nature (1974) 0.83
Nucleotide sequence of the 3' terminal region of the LEU2 gene from Saccharomyces cerevisiae. Gene (1984) 0.83
Interaction between hormone replacement therapy preparations and oral anticoagulant therapy. BJOG (2003) 0.82
Combined prednisolone and intravenous immunoglobulin treatment for acquired factor VIII inhibitors: a 2-year review. Haemophilia (2001) 0.82
Hepatitis C virus infection in patients with lymphoproliferative disorders. Br J Haematol (1996) 0.81
Intraperitoneal cultivation of small-cell carcinoma induces expression of the retinal cancer-associated retinopathy antigen. Arch Ophthalmol (1993) 0.81
Changing patterns of bleeding in patients with severe haemophilia A. Haemophilia (2009) 0.81
Depression and pain behavior in patients with chronic pain. Clin J Pain (1994) 0.81
Hydrogenase genes. Basic Life Sci (1981) 0.80
Molecular characterization of 11 novel mutations in patients with heterozygous and homozygous FV deficiency. Haemophilia (2010) 0.80
Anticoagulation with warfarin downregulates inflammation. J Thromb Haemost (2003) 0.80
A two-phase audit of fresh frozen plasma: a regional approach. Transfus Med (2004) 0.79
The short form of the Beck Depression Inventory: validity issues with chronic pain patients. Clin J Pain (1994) 0.79
Human brain glycogen phosphorylase: characterization of fetal cDNA and genomic sequences. Brain Res Mol Brain Res (1989) 0.79
Superficial vein thrombosis: incidence in association with pregnancy and prevalence of thrombophilic defects. Thromb Haemost (1998) 0.78
Toxoplasmosis after BMT for CML. Bone Marrow Transplant (1990) 0.78
Evaluating Patients with Chronic Pain and their Families: How you can recognize maladaptive patterns. Can Fam Physician (1991) 0.78
Risk of recurrence after a first unprovoked venous thromboembolism: external validation of the Vienna Prediction Model with pooled individual patient data. J Thromb Haemost (2015) 0.78
Plasma protein Z deficiency is common in women with antiphospholipid antibodies. Br J Haematol (2003) 0.78
Two novel antithrombin variants, Asn187Asp and Asn187Lys, indicate a functional role for asparagine 187. Blood Coagul Fibrinolysis (1995) 0.78
Reversal of asymptomatic over-anticoagulation with oral vitamin K. Br J Haematol (2006) 0.77
Role of E and CArG boxes in developmental regulation of muscle glycogen phosphorylase promoter during myogenesis. DNA Cell Biol (1998) 0.77
Hepatitis C infection and outcomes in the Scottish haemophilia population. Haemophilia (2013) 0.77
Agoraphobia without panic: case illustrations of an overlooked syndrome. J Nerv Ment Dis (1996) 0.77
Pain distribution, intensity, and duration in patients with chronic pain. J Pain Symptom Manage (1989) 0.77
DNA repair in DNA-polymerase-deficient mutants of Escherichia coli. Basic Life Sci (1975) 0.76
Antithrombin Cambridge II, 384 Ala to Ser. Further evidence of the role of the reactive centre loop in the inhibitory function of the serpins. FEBS Lett (1991) 0.76
Antithrombin cambridge II (Ala384Ser): clinical, functional and haplotype analysis of 18 families. Thromb Haemost (1998) 0.76
Prevalence of very severe headache in a large US metropolitan area. Cephalalgia (1989) 0.76
Psychological assessment in chronic pain. J Clin Psychol (1985) 0.76
Stenotrophomonas maltophilia: an increasing problem in patients with acute leukaemia. Leuk Lymphoma (1999) 0.76
Ischaemic heart disease in New Zealand Maori and non-Maori: an age adjusted incidence in hospitalised patients over 10 years with emphasis on clinical features in the Maori. Aust N Z J Med (1982) 0.76
Antithrombin III activity in healthy blood donors: age and sex related changes and prevalence of asymptomatic deficiency. Br J Haematol (1990) 0.76
Long-term follow-up of chronic pain patients: a preliminary study. Int J Psychiatry Med (1986) 0.76
Characterization of the 5' flanking region of the gene encoding rat liver glycogen phosphorylase. Gene (1993) 0.75
Low-molecular-weight heparin as optimal solution to therapeutic heparinization. Am Heart J (2000) 0.75
Treatment of acquired haemophilia. Intern Med J (2002) 0.75
Activated protein C resistance in normal pregnancy. Br J Obstet Gynaecol (1998) 0.75
Prevalence of temporomandibular symptoms in a large United States metropolitan area. Cranio (1990) 0.75
Activated protein C resistance in normal pregnancy. Br J Obstet Gynaecol (1998) 0.75
Diagnosis of APC Resistance during pregnancy. Br J Haematol (1996) 0.75
Asymptomatic coinheritance of heterozygous plasminogen deficiency and the factor VLeiden mutation. Blood Coagul Fibrinolysis (1997) 0.75
A preliminary comparison of healthy elderly and young adults on the SUNYA Revision of the Psychosomatic Symptom Checklist. J Psychosom Res (1990) 0.75
Antithrombin concentrate alone may not prevent venous thromboembolism following neurosurgery. Br J Haematol (1998) 0.75
Acquired activated protein C resistance in pregnancy is not due to elevated plasma caeruloplasmin levels. Br J Haematol (1999) 0.75